AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 2 analysts
Fundamentals
Fundamentals institutional score is 14 using growth durability 14.2.
Valuation
Valuation institutional score is 100 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 74 using mean target upside 27.7%; dispersion penalty 9.9; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 38 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 5 recent ticker-linked news items.
Signal Summary
Market intelligence remains Mixed. valuation and analyst consensus provide support, while fundamentals and technical structure remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 39.8% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -2.31). Confidence: 83%.
Live forward EPS implies next-12-month EPS of ₹296.40. Applying the stock's normalized valuation corridor produces a fair range of ₹15,587.68 to ₹19,420.13, with base value near ₹17,143.78 (+102.1% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹296.40
Forward P/E
28.6x
Base Fair Value
₹17,143.78
Fair Range
₹15,587.68 - ₹19,420.13
Upside To Base
+102.1%
Estimate Source
Live forward EPS
Growth Estimate
-34.3%
5Y Average
55.92
Current
34.84
Overvalued
65.52
Undervalued
52.59
5Y Average
40.39
Current
25.12
Overvalued
44.94
Undervalued
38.63
5Y Average
10.43
Current
6.49
Overvalued
11.60
Undervalued
9.97
Peers & Comparison
Sector: Consumer Staples · Theme: FMCG - Personal Products
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
EMAMI LIMITED EMAMILTDFMCG - Personal Products | +14.9% | 19.1% | 23.9x Undervalued | -71% vs avg | -29.2% |
BAJAJ CONSUMER CARE LTD BAJAJCONFMCG - Personal Products | +28.1% | 18.1% | 32.5x Undervalued | -61% vs avg | +131.7% |
HONASA CONSUMER LIMITED HONASAFMCG - Personal Products | +23.2% | 8.4% | 78.1x Fair | -6% vs avg | +79.3% |
MARICO LIMITED MARICOFMCG - Personal Products | +21.4% | 13.2% | 59.3x Undervalued | -28% vs avg | +21.9% |
CUPID LIMITED CUPIDFMCG - Personal Products | +162.5% | 29.5% | 332.5x Premium | +302% vs avg | +693.7% |
DABUR INDIA LTD DABURFMCG - Personal Products | +10.6% | 14.6% | 37.3x Undervalued | -55% vs avg | -19.6% |
COLGATE PALMOLIVE LTD. COLPALFMCG - Personal Products | +11.8% | 21.7% | 40.8x Undervalued | -51% vs avg | -8.2% |
GODREJ CONSUMER PRODUCTS GODREJCPFMCG - Personal Products | +15.4% | 12.1% | 56.9x Undervalued | -31% vs avg | -12.5% |
P&G HYGIENE & HEALTH CARE trades at a discount (34.8x vs peer avg 82.7x), suggesting potential undervaluation relative to the Fmcg - Personal Products cohort. Peers include EMAMI LIMITED, BAJAJ CONSUMER CARE LTD, HONASA CONSUMER LIMITED — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹891 CrJun 2026Latest net profit
₹126 CrJun 2026Latest EPS
₹38.90Jun 2026Net margin
19.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 853 | 1,138 | 1,133 | 1,002 | 932 | 1,135 | 1,248 | 992 | 937 | 1,150 | 1,262 | 941 | 891 |
| Expenses + | 638 | 853 | 824 | 745 | 813 | 845 | 877 | 782 | 671 | 865 | 860 | 723 | 721 |
| Operating Profit | 215 | 285 | 310 | 257 | 118 | 290 | 371 | 210 | 266 | 285 | 402 | 218 | 170 |
| OPM % | 25% | 25% | 27% | 26% | 13% | 26% | 30% | 21% | 28% | 25% | 32% | 23% | 19% |
| Other Income + | 10 | 16 | 16 | 14 | 7 | 8 | 10 | 19 | 8 | 10 | 12 | 12 | 9 |
| Interest | 3 | 2 | 3 | 22 | -0 | 2 | 7 | 6 | 0 | 4 | 3 | 3 | 0 |
| Depreciation | 15 | 14 | 14 | 15 | 13 | 12 | 10 | 10 | 9 | 9 | 10 | 10 | 10 |
| Profit before tax | 207 | 284 | 309 | 234 | 112 | 285 | 364 | 213 | 265 | 282 | 402 | 218 | 170 |
| Tax % | 27% | 26% | 26% | 34% | 28% | 26% | 26% | 27% | 27% | 26% | 25% | 30% | 26% |
| Net Profit + | 151 | 211 | 229 | 154 | 81 | 212 | 269 | 156 | 192 | 210 | 301 | 153 | 126 |
| EPS in Rs | 46.59 | 64.91 | 70.52 | 47.56 | 24.97 | 65.28 | 82.74 | 48.09 | 59.17 | 64.65 | 92.87 | 47.17 | 38.90 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Intimation Of 62Nd Annual General Meeting Of The Company To Be Held On September 8, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release